Stockreport

Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF – Renee Gala named as President and CEO, effective August 11 –– Total revenues of $1.05 billion in 2Q25 –– Xywav® revenues grew 13% year-over-year, with robust net patie [Read more]